Skip to main content

Unit Cohesion clinical trials at UCSF
1 in progress, 1 open to new patients

  • Intranasal Oxytocin and Enhancement of Team Cohesion

    open to eligible people ages 18–28

    This study attempts to identify the psychological, behavioral, physiological, and hormonal predictors and mechanisms of an individual's ability to develop cohesion in a group working together as a team; and examine if administration of the prosocial neuropeptide oxytocin enhances the development of team cohesion. Through a deeper understanding of the underlying psychobiological predictors and mechanisms of team cohesion, the prospective identification of individuals whose unique characteristics promote or inhibit the development of group cohesion will become possible.

    San Francisco, California